Cantor Fitzgerald initiated coverage on Novan with a new price target
$NOVN
Biotechnology: Pharmaceutical Preparations
Health Care
Cantor Fitzgerald initiated coverage of Novan with a rating of Overweight and set a new price target of $30.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 9/24/2021 | $28.00 → $24.00 | Buy | HC Wainwright & Co. |
| 7/9/2021 | $30.00 | Overweight | Cantor Fitzgerald |